Edema and Fibrosis CMR Imaging in Cardiomyopathy

Edema and Fibrosis Cardiac Magnetic Resonance Imaging in Cardiomyopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03534726

Enrollment

Registered

2018-05-23

Start date

2018-02-01

Completion date

2027-12-31

Last updated

2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathies

Brief summary

7 Tesla MRI is a new magnetic field strength that has become available at Penn for cardiovascular MRI. This new scanner has potential to improve assessment of cardiovascular disease due to its increased signal-to-noise ratio, higher spatial resolution, and response to magnetic properties of tissue at high field. The purpose of this study is to assess the feasibility of 7 T CMR. Secondly, we wish to investigate its use, to improve clinical and research MRI. Altogether, 7 T may permit better clinical diagnosis of cardiomyopathy.

Interventions

DEVICE7 T CMR

7 tesla MRI device

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Subjects between the ages of 20-70 years old

Exclusion criteria

* Advanced renal disease (estimated GFR rate \< 30 mL/min) or hypersensitivity to gadolinium contrast agent. * Presence of cardiac pacemaker or implanted cardioverter defibrillator * Pregnancy * Inability to provide informed consent * Other contraindications to MRI (such as claustrophobia)

Design outcomes

Primary

Measure	Time frame
ejection fraction	5 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026